
Protein Sequencing Market Report 2026
Global Outlook – By Product And Service (Protein Sequencing Products, Protein Sequencing Services), By Application (Bio-Therapeutics, Genetic Engineering, Other Applications), By End User (Pharmaceutical And Biotechnology Companies, Other End-Users ) - Market Size, Trends, And Global Forecast 2026-2035
Protein Sequencing Market Overview
• Protein Sequencing market size has reached to $1.87 billion in 2025 • Expected to grow to $2.86 billion in 2030 at a compound annual growth rate (CAGR) of 8.5% • Growth Driver: Genetic Illness Propels Protein Sequencing Market Growth • Market Trend: Technologically Advanced Kits For Providing Accessible And Cost-Efficient Alternately • North America was the largest region in 2025 and Europe is the fastest growing region.What Is Covered Under Protein Sequencing Market?
Protein sequencing refers to the process of determining the precise order of amino acids within a protein or peptide. This technique is used to determine the precise order of amino acids within a protein molecule, which is crucial for understanding its structure and function in biomedical research The main products and services of protein sequencing are protein sequencing products and protein sequencing services. Protein sequencing products refer to tools and materials used in determining the order of amino acids in proteins. The various applications included are bio-therapeutics, genetic engineering, and other applications, which are used by end users such as pharmaceutical and biotechnology companies, and other end-users.
What Is The Protein Sequencing Market Size and Share 2026?
The protein sequencing market size has grown rapidly in recent years. It will grow from $1.87 billion in 2025 to $2.06 billion in 2026 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to expansion of biomedical research activities, increasing demand for protein structure analysis, growth of pharmaceutical R&D investments, availability of advanced analytical instruments, rising focus on molecular biology studies.What Is The Protein Sequencing Market Growth Forecast?
The protein sequencing market size is expected to see strong growth in the next few years. It will grow to $2.86 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to increasing demand for personalized medicine research, rising investments in proteomics-based drug discovery, expansion of bioinformatics-enabled sequencing platforms, growing adoption of automated sequencing workflows, increasing focus on biomarker identification. Major trends in the forecast period include increasing adoption of high-throughput protein sequencing techniques, rising use of advanced mass spectrometry methods, growing integration of bioinformatics in sequencing workflows, expansion of custom protein sequencing services, enhanced focus on high-accuracy sequencing outputs.Global Protein Sequencing Market Segmentation
1) By Product And Service: Protein Sequencing Products, Protein Sequencing Services 2) By Application: Bio-Therapeutics, Genetic Engineering, Other Applications 3) By End User: Pharmaceutical And Biotechnology Companies, Other End-Users Subsegments: 1) By Protein Sequencing Products: Sequencing Kits, Reagents, Instruments, Consumables 2) By Protein Sequencing Services: Custom Protein Sequencing, Analytical Protein Sequencing, Bioinformatics Services, Proteomics ServicesWhat Is The Driver Of The Protein Sequencing Market?
The rise in genetic illness is expected to propel the growth of the protein sequencing market going forward. A genetic illness refers to any disease or disorder that is caused by abnormalities or mutations in an individual's genetic material, generally their DNA. The rise in genetic illness is caused due to genetic mutations that can occur spontaneously or be inherited from parents. Protein sequencing can help identify specific genetic variants responsible for causing diseases thereby helping identify protein biomarkers, which are molecules indicative of a particular disease state or physiological condition. For instance, in October 2024, according to the Cystic Fibrosis Trust, a UK-based national charity, 11,148 people were living with cystic fibrosis (CF) in the UK in 2022, increasing to 11,318 in 2023. Therefore, the rise in genetic illness is driving the growth of the protein sequencing industry.Key Players In The Global Protein Sequencing Market
Major companies operating in the protein sequencing market are F Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Merck KGaA, Eurofins Scientific SE, Beckman Coulter Inc, PerkinElmer Inc, GenScript Biotech Corporation, Agilent Technologies Inc, CeMIA SA, Shimadzu Corporation, Bruker Corporation, Waters Corporation, Bio-Rad Laboratories Inc, SCIEX, Protein Metrics Inc, Alphalyse A S, Rapid Novor Inc, Creative Proteomics, Bioproximity LLC, Protagen AG, MS Bioworks LLC, Charles River Laboratories IncGlobal Protein Sequencing Market Trends and Insights
Major companies operating in the protein sequencing market are developing advanced technology products that are upgraded, such as sequencing kits, to gain a competitive edge in the market. Sequencing kits are collections of reagents, chemicals, and materials required to prepare samples and conduct sequencing experiments. For instance, in February 2024, Quantum-Si, a US-based protein sequencing company, launched Protein Sequencing Kit V2, an enhancement for its Platinum protein sequencing platform. It offers increased sequencing performance with assay improvements, including the addition of a new amino acid recognizer, as well as the ability to identify unknown proteins through advanced analytical and inference tools. These upgrades provide increased sequencing performance, the ability to identify unknown proteins, high reproducibility, and a three-fold reduction in cost per amino acid.What Are Latest Mergers And Acquisitions In The Protein Sequencing Market?
In October 2023, Thermo Fisher Scientific, a US-based biotechnology company acquired Olink Holding AB for an amount of $3.1 billion. The acquisition is expected to enhance Thermo Fisher's capabilities in the high-growth proteomics market, providing highly differentiated complements to its existing life sciences and mass spectrometry offerings. Olink Holding AB is a Sweden-based company dedicated to accelerating proteomics together with the scientific community across multiple disease areas to enable new discoveries and improve the lives of patients.Regional Outlook
North America was the largest region in the protein sequencing market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Protein Sequencing Market?
The protein sequencing market consists of revenues earned by providing services such as N-terminal protein sequencing, de novo amino acid sequencing, peptide mapping, de novo antibody sequencing, and amino acid analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The protein sequencing also includes sales of mass spectrometry instruments and Edman degradation sequencers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Protein Sequencing Market Report 2026?
The protein sequencing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the protein sequencing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Protein Sequencing Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $2.06 billion |
| Revenue Forecast In 2035 | $2.86 billion |
| Growth Rate | CAGR of 10.1% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product And Service, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | F Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Merck KGaA, Eurofins Scientific SE, Beckman Coulter Inc, PerkinElmer Inc, GenScript Biotech Corporation, Agilent Technologies Inc, CeMIA SA, Shimadzu Corporation, Bruker Corporation, Waters Corporation, Bio-Rad Laboratories Inc, SCIEX, Protein Metrics Inc, Alphalyse A S, Rapid Novor Inc, Creative Proteomics, Bioproximity LLC, Protagen AG, MS Bioworks LLC, Charles River Laboratories Inc |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
